New Zealand markets close in 1 hour 14 minutes

Eargo, Inc. (EAR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2300-0.0800 (-6.11%)
At close: 04:00PM EDT
1.3100 +0.08 (+6.50%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.3100
Open1.2300
Bid1.2800 x 3200
Ask1.3000 x 1800
Day's range1.2300 - 1.3700
52-week range0.6700 - 36.9600
Volume4,300,784
Avg. volume3,668,114
Market cap48.411M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Eargo to Report Second Quarter 2022 Financial Results on August 8, 2022

    SAN JOSE, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the second quarter 2022 after market close on August 8, 2022. On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights. Interested parties may access the live call via telephone by dialing (

  • GlobeNewswire

    Eargo Closes First Tranche Investment of $100 Million from Patient Square Capital

    SAN JOSE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it has completed the issuance of $100 million aggregate principal amount of senior secured convertible notes to Patient Square Capital on June 28, 2022 (the “First Tranche Investment”). The Company used approximately $16.3 million of the net proceeds to repay all existing third-party indebt

  • GlobeNewswire

    Eargo Strengthens Financial Position with up to $125 Million Strategic Investment from Patient Square Capital

    Company to Hold Conference Call and Webcast on June 27, 2022 at 8 a.m. Eastern TimeSAN JOSE, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it has signed a definitive agreement with Patient Square Capital (“Patient Square”) to raise $100 million through the sale of senior secured convertible notes, with an additional $25 million future investment